Mammalian Cell Culture Market Research Reveals Strong 10.8% CAGR Outlook Through 2030

An Overview of the Mammalian Cell Culture Market's Growth and Potential
The mammalian cell culture industry is set for significant expansion in the coming years. Projections estimate that by 2030, the market size will reach $8.13 billion, growing at a compound annual growth rate (CAGR) of 10.8%. This upward trajectory is largely driven by factors such as increased investments in cell and gene therapies, a growing need for biologics manufacturing, expanding regenerative medicine research, and a heightened emphasis on scalable culture technologies and continuous bioprocessing methods. Key trends anticipated to influence the market include the rising use of serum-free media, the surge in demand for large-scale biopharmaceutical production, wider adoption of automated cell culture platforms, growth in cell-based vaccine manufacturing, and a stronger focus on optimizing process consistency and yields.

Key Companies Leading the Mammalian Cell Culture Market
The mammalian cell culture sector features several prominent players shaping its development. Leading companies include Novartis AG, Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, GE Healthcare, Becton dic*kinson and Company, Lonza Group AG, Avantor Inc., Agilent Technologies Inc., Charles River Laboratories, Sartorius AG, Samsung Biologics, Wuxi Biologics, Bio-Techne Corporation, Miltenyi Biotec, STEMCELL Technologies, Takara Bio Inc., Goodwin Biotechnology, HiMedia Laboratories Private Limited, Promocell GmbH, Eppendorf AG, Cell Culture Company LLC, and Cell X Technologies.

The mammalian cell culture market size has grown rapidly in recent years. It will grow from $4.86 billion in 2025 to $5.4 billion in 2026 at a compound annual growth rate (CAGR) of 11.1%. The growth in the historic period can be attributed to expansion of monoclonal antibody production, growth in vaccine manufacturing capacity, increasing use of mammalian cells in drug discovery, rising availability of advanced culture equipment, growth of biopharmaceutical research.

Download a free sample of the mammalian cell culture market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=30318&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Recent Acquisition Highlighting Market Innovation
In December 2024, Merck KGaA, a Germany-based science and technology company, completed the acquisition of HUB Organoids Holding B.V., a biotechnology firm from the Netherlands, for an undisclosed amount. This strategic move aims to enhance Merck's portfolio in next-generation biology by integrating HUB's advanced organoid technology. The acquisition will accelerate drug discovery processes, expand capabilities in 3D cell culture, and provide improved human-relevant models for disease research and toxicity testing. HUB Organoids specializes in mammalian cell culture-based organoid models that replicate human organ structures and functions, enabling breakthroughs in both research and therapeutic fields.

Innovations Boosting Mammalian Cell Culture Market Growth
Industry leaders are actively advancing cell culture media technology to improve therapeutic product yields and cell viability while streamlining bioprocess workflows. One notable innovation is the two-part production system, which uses separate media components-one to support cell growth and another to enhance protein expression-resulting in higher productivity. For example, in July 2023, Switzerland-based contract development and manufacturing organization Lonza Group Ltd. introduced the TheraPRO CHO Media System. This chemically defined, animal-component-free media is designed specifically for GS-CHO mammalian cell lines and aims to boost production of therapeutic proteins and monoclonal antibodies. Its scalable formula supports all bioprocessing stages, from early cell line development to large-scale manufacturing, helping biopharmaceutical companies optimize quality and speed to market.

View the full mammalian cell culture market report:
https://www.thebusinessresearchcompany.com/report/global-mammalian-cell-culture-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Structure and Segmentation of the Mammalian Cell Culture Market
This report categorizes the mammalian cell culture market into several key segments. By product, it includes media, sera, reagents, and equipment. Cell line categories cover Chinese Hamster ovary* (CHO), Wistar Institute-38 (WI-38), Rat Glial Tumor Cell Line (C6), Human Embryonic Kidney 293 (HEK293), and Henrietta Lacks (HeLa). Applications range from biopharmaceutical production and vaccine manufacturing to toxicity testing, drug screening and development, as well as tissue engineering and regenerative medicine. The end-users are classified into pharmaceutical and biotechnology companies, hospitals and diagnostic labs, research and academic institutions, and contract research organizations (CROs).

Detailed Subdivisions Within Each Market Category
Further breakdown of the market segments includes media types such as serum-free, chemically defined, classical, protein-free, specialty, and custom formulations. Sera are divided into fetal bovine serum (FBS), newborn calf serum, adult bovine serum, and donor horse serum. Reagents incorporate growth factors and cytokines, cell dissociation reagents, supplements and additives, cryoprotective agents, buffers and salt solutions, alongside antibiotics and antimycotics. Equipment covers bioreactors and fermenters, culture vessels, filtration systems, centrifuges, cell counters and analyzers, incubators, biosafety cabinets, microscopes, and refrigeration and cryostorage apparatus.

Expanded capabilities in our 2026 market reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.